Cargando…

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation

Antibody-mediated rejection (AMR) is caused by antibodies that recognize donor human leukocyte antigen (HLA) or other targets. As knowledge of AMR pathophysiology has increased, a combination of factors is necessary to confirm the diagnosis and phenotype. However, frequent modifications to the AMR d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roufosse, Candice, Becker, Jan Ulrich, Rabant, Marion, Seron, Daniel, Bellini, Maria Irene, Böhmig, Georg A., Budde, Klemens, Diekmann, Fritz, Glotz, Denis, Hilbrands, Luuk, Loupy, Alexandre, Oberbauer, Rainer, Pengel, Liset, Schneeberger, Stefan, Naesens, Maarten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163810/ https://www.ncbi.nlm.nih.gov/pubmed/35669973 http://dx.doi.org/10.3389/ti.2022.10140

Ejemplares similares

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
por: Becker, Jan Ulrich, et al.
Publicado: (2022)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group
por: Mamode, Nizam, et al.
Publicado: (2022)

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
por: Delpire, Boris, et al.
Publicado: (2022)

Editorial: Transplant International Goes for GOLD!
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Editorial: Rubies for ESOT!
por: Berney, Thierry, et al.
Publicado: (2022)

Reflecting on an Intense Year for Transplant International
por: Berney, Thierry, et al.
Publicado: (2022)

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials
por: Haas, M., et al.
Publicado: (2018)

European Society for Organ Transplantation (ESOT)-TLJ 3.0 Consensus on Histopathological Analysis of Pre-Implantation Donor Kidney Biopsy: Redefining the Role in the Process of Graft Assessment
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Xenotransplantion: Defeating the “Shumway Curse” An Interview With Drs. Bartley Griffith, Jayme Locke, Robert Montgomery, and Bruno Reichart
por: Berney, Thierry, et al.
Publicado: (2022)

Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe
por: Rostaing, Lionel P. E., et al.
Publicado: (2023)

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes
por: Klein, Amanda, et al.
Publicado: (2023)

Banff Human Organ Transplant Consensus Gene Panel for the Detection of Antibody Mediated Rejection in Heart Allograft Biopsies
por: Giarraputo, Alessia, et al.
Publicado: (2023)

Steroid Sparing Maintenance Immunosuppression in Highly Sensitised Patients Receiving Alemtuzumab Induction
por: Santos, Eva, et al.
Publicado: (2023)

Immune Profiling of Peripheral Blood Mononuclear Cells at Pancreas Acute Rejection Episodes in Kidney-Pancreas Transplant Recipients
por: Rovira, Jordi, et al.
Publicado: (2022)

Eliminating Race From eGFR Calculations: Impact on Living Donor Programs
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Back to the Future With Co-Stimulation Blockade
por: Flechner, Stuart M., et al.
Publicado: (2023)

Is Preemptive Kidney Transplantation Associated With Improved Outcomes when Compared to Non-preemptive Kidney Transplantation in Children? A Systematic Review and Meta-Analysis
por: Rana Magar, Reshma, et al.
Publicado: (2022)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
por: van den Broek, Dennis A. J., et al.
Publicado: (2023)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Embracing the Wisdom of Ancient Greece in the Era of Personalized Medicine—Uncertainty, Probabilistic Reasoning, and Democratic Consensus
por: Naesens, Maarten
Publicado: (2023)

Can We Predict Graft Intolerance Syndrome After Kidney Transplant Failure? External Validation of a Previously Developed Model
por: Bunthof, Kim, et al.
Publicado: (2023)

Equity, Diversity and Inclusion (EDI) in Organ Transplantation: An ESOT Survey About EDI Within ESOT as an Organization and its Educational Activities, and Transplantation Research and Science
por: Pengel, L. H. M., et al.
Publicado: (2023)

Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?
por: Van Loon, Elisabet, et al.
Publicado: (2023)

Impact of COVID-19 on Global Kidney Transplantation Service Delivery: Interim Report
por: Papalois, Vassilios, et al.
Publicado: (2022)

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
por: Loupy, A., et al.
Publicado: (2016)

The Role of the Duffy Blood Group Antigens in Renal Transplantation and Rejection. A Mini Review
por: Hariri, Dana, et al.
Publicado: (2023)

Application of Intestinal Barrier Molecules in the Diagnosis of Acute Cellular Rejection After Intestinal Transplantation
por: Chen, Yun, et al.
Publicado: (2023)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: van Vugt, Lukas K., et al.
Publicado: (2023)

ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
por: Cillo, Umberto, et al.
Publicado: (2022)

Modeling the Potential of Treg-Based Therapies for Transplant Rejection: Effect of Dose, Timing, and Accumulation Site
por: Lapp, Maya M., et al.
Publicado: (2022)

Clinical Significances of Anti-Collagen Type I and Type III Antibodies in Antibody-Mediated Rejection
por: Park, Sehoon, et al.
Publicado: (2022)

Dysbiosis and Depletion of Fecal Organic Acids Correlate With the Severity of Rejection After Rat Liver Transplantation
por: Yao, Siyuan, et al.
Publicado: (2022)

Assessment of Acute Rejection in a Lung Transplant Recipient Using a Sentinel Skin Flap
por: Haykal, Siba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cql7s71sf4uhqgmmeb0j56hoks